Rechercher un essai clinique
Autre(s) option(s) de recherche
14 Résultat(s)
Essai en cours de recrutement = 
; Essai en cours = 
; Financé par un membre IRDiRC = 
Essai(s) clinique(s) national(aux)
ESPAGNE
Cataluña
BARCELONA
A randomised, double-blind, placebo-controlled proof-of concept study of the efficacy of gevokizumab 60mg subcutaneously every 4 weeks over 24 weeks in the treatment of patients with polymyositis or dermatomyositis disease (Phase II) - ES
Hospital Universitari Vall d'Hebron
Servicio de Medicina Interna
FRANCE
ILE-DE-FRANCE
PARIS
Tolérance et efficacité d'une immunoglobuline humaine normale en administration intraveineuse dans le traitement des dermatomyosites et des polymyosites (Phase III)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Département de Médecine Interne et Immunologie Clinique
HONGRIE
Közép-Magyarország
BUDAPEST
A double blind, randomized, placebo-controlled study to evaluate, safety, tolerability, efficacy and preliminary dose-response of BAF312 in patients with active dermatomyositis.
Institute of Genomic Medicine and Rare Disorders, Semmelweis University
Genetics Laboratory
HONGRIE
Közép-Magyarország
BUDAPEST
A randomised, double-blind, placebo-controlled proof-of concept study of the efficacy of gevokizumab 60mg subcutaneously every 4 weeks over 24 weeks in the treatment of patients with polymyositis, dermatomyositis or necrotizing autoimmune myophaty disease
Institute of Genomic Medicine and Rare Disorders, Semmelweis University
Genetics Laboratory
ITALIE
LIGURIA
GENOVA
Five-year actively controlled clinical trial in new onset juvenile dermatomyositis
IRCCS Istituto G. Gaslini - Ospedale Pediatrico
U.O. Pediatria II
PAYS-BAS
Noord-Holland
AMSTERDAM
Dexa-Myositis Trial: treatment of polymyositis and dermatomyositis - dexamethasone versus prednisone
Amsterdam UMC, locatie AMC
Afdeling Neurologie
PAYS-BAS
Noord-Holland
AMSTERDAM
IMMEDIATE: Intravenous immunoglobulins as early treatment in newly diagnosed idiopathic inflammatory myopathies: a pilot study
Amsterdam UMC, locatie AMC
Afdeling Neurologie
ROYAUME-UNI
Greater London
LONDON
RBHIPF004 - A randomized, double blind controlled trial comparing rituximab against intravenous cyclophosphamide in connective tissue disease associated interstitial lung disease
National Heart and Lung Institute, Imperial College, Royal Brompton Campus
Interstitial Lung Disease Unit
ROYAUME-UNI
Greater Manchester
MANCHESTER
TARGET: A prospective randomised controlled trial of thiopurine methyltransferase (TPMT) genotyping in the management of patients, prior to commencement of azathioprine treatment (Phase IV)
Nowgen - A Centre for Genetics in Healthcare
FRANCE
ILE-DE-FRANCE
GARCHES
Long-Term Effect of LIAM (Lung Insufflation Assist Maneuver) on Respiratory Performance in Non-invasive Ventilated Patients Suffering From Neuromuscular Disease
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Centre d'Investigation Clinique et Technologique 805 - CIC-IT de Garches
FRANCE
ILE-DE-FRANCE
GARCHES
Protocole de Validation Clinique du Logiciel d'Interface Cerveau-Ordinateur RoBIK Pour la Communication Des Patients Atteints de Maladie Neuromusculaires (MNM)
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Centre d'Investigation Clinique et Technologique 805 - CIC-IT de Garches
FRANCE
ILE-DE-FRANCE
GARCHES
Establishment of a Non-invasive and Indirect Measure of Volitional Pimax (PI MAX STIM)
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Physiologie-Explorations Fonctionnelles
FRANCE
ILE-DE-FRANCE
PARIS
Nemucough : Evaluation d'un dispositif d'insufflation/exsufflation mécanique en cas de déficit respiratoire aigu chez des patients atteints de pathologies neuromusculaires : une étude prospective, randomisée, contrôlée et multicentrique (Phase III)
CHU Paris Est - Hôpital d'Enfants Armand-Trousseau
Service de pneumologie pédiatrique
Essai(s) clinique(s) multinational(aux)
FRANCE
ILE-DE-FRANCE
PARIS